Subsequently, Blee and colleagues showed that, in the context of Pten/Tp53 alterations, ERG is important for maintaining the luminal epithelial lineage in prostate cancer cells by repressing the expression of cell cycle genes and upregulating AR pathway genes (52). This evidence concerns the gene TP53 and prostate cancer.